Sustainable Healthcenter Implementation PrEP Pilot Study — SHIPP

HIV Preexposure Prophylaxis Clinical Trial

Official title:
Sustainable Healthcenter Implementation PrEP Pilot Study

Status Completed

Clinical Trial Summary

A health services implementation pilot study, conducted with an observational cohort of HIV-uninfected persons including men who have sex with men, heterosexual women and men, and injection drug users receiving daily oral antiretroviral preexposure prophylaxis (PrEP) at four federally qualified health centers that provide sexual health and primary care services to communities with high HIV incidence/prevalence.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02074891
Study type	Observational
Source	Centers for Disease Control and Prevention
Contact
Status	Completed
Phase
Start date	October 2014
Completion date	November 2018

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04754139` - A Promotion and Implementation Project of HIV Pre-Exposure Prophylaxis Among High Risk Population	N/A
Completed	`NCT04424524` - Streamlining the Efficiency of PrEP Implementation
Completed	`NCT04652700` - Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Are at High Risk for HIV-1 Infection (MK-8591-024)	Phase 3
Recruiting	`NCT03893188` - The SwissPrEPared Study